See What HealthDay Can Do For You
Contact Us

DKA Episode May Harm Cognitive Function in Children With T1D

Lower IQ and worse memory seen in children with newly diagnosed type 1 diabetes and single event

sick child

FRIDAY, Oct. 9, 2020 (HealthDay News) -- A single diabetic ketoacidosis (DKA) episode is associated with subtle memory declines soon after type 1 diabetes diagnosis in children, according to a study published online Sept. 22 in Diabetes Care.

Simona Ghetti, from the University of California, Davis, and colleagues assessed whether a single DKA episode is associated with cognitive deficits in children with type 1 diabetes. Data were analyzed for a total of 758 children (aged 6 to 18 years old) who participated in a clinical trial to evaluate various intravenous fluid protocols for DKA.

The researchers found that DKA was moderate/severe in 430 children and mild in 328 children. Among children who presented with DKA, 392 had a new onset of type 1 diabetes and the remainder previously had received a diagnosis. Moderate/severe DKA was associated with lower intelligence quotient (IQ), item-color recall, and forward digit span. Moderate/severe DKA in newly diagnosed patients was associated with lower item-color recall. When adjusting for hypoglycemia, diabetes duration, and socioeconomic status, repeated DKA exposure and higher HbA1c in previously diagnosed patients were independently associated with lower IQ and higher HbA1c was associated with lower item-color recall.

"Sizable IQ declines are detectable in children with known diabetes, suggesting that DKA effects may be exacerbated in children with chronic exposure to hyperglycemia," the authors write.

Abstract/Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.